Recent director dealings and insider transactions at UnitedHealth Group Incorporated (UNH),
from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
Date
Insider
Type
Shares
2026-07-01
Mcnabb Frederick William Iii
BUY
250
2026-07-01
Gil Kristen
BUY
206
2026-07-01
Montgomery Rice Valerie Md
BUY
220
2026-07-01
Noseworthy John H
BUY
206
2026-07-01
Baker Charles D.
BUY
220
2026-07-01
Flynn Timothy Patrick
BUY
225
2026-07-01
Gottlieb Scott
BUY
210
2026-07-01
Garcia Paul R
BUY
88
2026-07-01
Garcia Paul R
BUY
132
2026-06-23
Stankiewicz Dennis Andrew
BUY
51
Valuation
P/E RatioN/A
Market Cap$382.83B
Beta0.633
Dividend/yrNone
52W High$461.62
52W Low$234.60
52-Week Range
$234.60Now$461.62
82% through annual range
From 52W High−8.7%
From 52W Low+79.7%
📖 Plain English Summary
UnitedHealth Group Incorporated is at 82% of its 52-week range. Beta 0.633 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for UNH🟢 Bullish⬜ Neutral🔴 Bearish
🤖
DipBuster AI Analysis — UNH
Heuristic · balance sheet, insider filings, price data, academic research
UnitedHealth Group Incorporated — DipBuster Score 20/100
Graham value assessment, NCAV analysis, price zones...
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, a…